Influence of ezetimibe in addition to high-dose atorvastatin therapy on plaque composition in patients with ST-segment elevation myocardial infarction assessed by serial: Intravascular ultrasound with iMap: the OCTIVUS trial.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The aim of this study was to examine the influence of ezetimibe in addition to atorvastatin on plaque composition in patients with first-time ST-segment Elevation Myocardial Infarction treated with primary percutaneous intervention.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Cardiovasc Revasc Med

Title: Cardiovascular revascularization medicine : including molecular interventions

Publisher: Elsevier BV

ISSN (Electronic): 1878-0938

ISSN (Print): 1878-0938

Publication date (Electronic): Mar 2017

Volume: 18

Issue: 2

Affiliations

[1 ] Department of Cardiology, Odense University Hospital, Odense, Denmark. Electronic address: Mikkel@candmed.dk.

[2 ] Department of Cardiology, Odense University Hospital, Odense, Denmark.

Article

Publisher Item ID: S1553-8389(16)30333-5

DOI: 10.1016/j.carrev.2016.11.010

PubMed ID: 27919638

SO-VID: 3189b9e6-a855-4f21-bfbc-c2d7df97e21b

History

Keywords: IVUS,iMap,Atorvastatin,Ezetimibe

Data availability:

Keywords: IVUS, iMap, Atorvastatin, Ezetimibe

Comments

Comment on this article

scite_

Cited by 18

See all cited by